Bryn Roberts, SVP & Global Head of Operations at Roche (pRED), explains how the R&D spectrum benefits from a range of emerging technologies.
Part of The Age of Transformation: How Pharma Can Harness the Power of Data, a series powered by Medidata.
Which emerging technologies does Roche apply across its R&D journey?
With an array of medicines and treatments in its portfolio - and therefore data - Roche is already applying cutting edge technology to gather insights.
CHANNELS
